Vikman Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-05-2024
- Paid Up Capital ₹ 0.25 M
as on 27-05-2024
- Company Age 13 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 1.67%
(FY 2020)
- Profit 0.45%
(FY 2020)
- Ebitda 0.45%
(FY 2020)
- Net Worth -1.67%
(FY 2020)
- Total Assets 17.87%
(FY 2020)
About Vikman Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Agarwal, Shilpi Agrawal, Reena Agrawal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24232WB2011PTC171082
- Company No.
171082
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vikman Pharmaceutical?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Agarwal  | Director | 22-Dec-2011 | Current |
| Shilpi Agrawal | Director | 29-Jul-2015 | Current |
| Reena Agrawal | Director | 29-Jul-2015 | Current |
| Mohan Chanduka | Director | 29-Jul-2015 | Current |
| Krishna Chanduka | Director | 29-Jul-2015 | Current |
| Vineet Agarwal | Director | 22-Dec-2011 | Current |
Financial Performance of Vikman Pharmaceutical.
Vikman Pharmaceutical Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 1.67% increase. The company also saw a slight improvement in profitability, with a 0.45% increase in profit. The company's net worth dipped by a decrease of 1.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vikman Pharmaceutical?
In 2020, Vikman Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vikman Pharmaceutical?
Unlock and access historical data on people associated with Vikman Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vikman Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikman Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
